Lind Penelope A, Eriksson C J Peter, Wilhelmsen Kirk C
Genetic Epidemiology, Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Queensland, Australia.
Psychiatr Genet. 2009 Jun;19(3):117-25. doi: 10.1097/YPG.0b013e32832a4f7b.
Ethanol-induced dopamine (DA) release in the mesolimbic system may reinforce excessive alcohol intake and the progression of alcohol dependence. Within this reward system, the DA transporter (DAT1) plays a key role in the regulation of dopaminergic neurotransmission through presynaptic DA reuptake.
This study investigated whether DAT1 genetic variation was associated with either alcohol consumption behavior or alcohol dependence in a Finnish cohort.
Eight single nucleotide polymorphisms and a frequently studied 3'-untranslated region 40-bp variable number tandem repeat were genotyped in unrelated male Finnish participants selected from alcoholism clinical treatment facilities (n=104), or through the Finnish Population Register (n=201). All participants completed the Alcohol Use Disorder Identification Test.
We found significant evidence that the synonymous exon 2 rs6350 variant was positively associated with both alcohol consumption behavior (P=0.0004) and problem drinking (G allele, odds ratio: 3.63, 95% confidence interval: 1.22-10.78). A second single nucleotide polymorphism, rs463379 (intron 4), was negatively associated with alcohol dependence (A allele, odds ratio: 0.61, 95% confidence interval: 0.39-0.94). However, two-locus haplotypic analysis of rs6350-rs463379 did not further increase the strength of association with the quantitative Alcohol Use Disorder Identification Test score trait (P=0.0024).
The present findings suggest that DAT1 genetic variation influences drinking behavior in our Finnish population, where the rs6350 A and rs463379 G alleles provide a protective role against high alcohol consumption and alcohol dependence, respectively. A systematic search for DAT1 variants that affect gene function or expression in the Finnish and other populations is warranted.
乙醇诱导中脑边缘系统多巴胺(DA)释放可能会强化过度饮酒及酒精依赖的进展。在这个奖赏系统中,DA转运体(DAT1)通过突触前DA再摄取在多巴胺能神经传递的调节中起关键作用。
本研究调查了DAT1基因变异是否与芬兰队列中的饮酒行为或酒精依赖相关。
在从酒精中毒临床治疗机构选取的无关芬兰男性参与者(n = 104)或通过芬兰人口登记处选取的参与者(n = 201)中,对8个单核苷酸多态性以及一个经常研究的3'非翻译区40 bp可变数目串联重复序列进行基因分型。所有参与者均完成酒精使用障碍识别测试。
我们发现有力证据表明,同义外显子2 rs6350变异与饮酒行为(P = 0.0004)和问题饮酒均呈正相关(G等位基因,比值比:3.63,95%置信区间:1.22 - 10.78)。第二个单核苷酸多态性rs463379(内含子4)与酒精依赖呈负相关(A等位基因,比值比:0.61,95%置信区间:0.39 - 0.94)。然而,rs6350 - rs463379的两位点单倍型分析并未进一步增强与定量酒精使用障碍识别测试评分性状的关联强度(P = 0.0024)。
目前的研究结果表明,DAT1基因变异影响我们芬兰人群的饮酒行为,其中rs6350 A和rs463379 G等位基因分别对高酒精消费和酒精依赖起到保护作用。有必要在芬兰及其他人群中系统搜索影响基因功能或表达的DAT1变异。